Innovations in Diagnostics, Treatment, and Technology for Nephrology and Urology

The 23^rd International Conference on Nephrology, Urology, and Therapeutics, held on March 20-21, 2025, in Rome, Italy, is a vital event for professionals in kidney and urological healthcare. This conference offers a platform to explore the latest breakthroughs in diagnostics, treatment methodologies, and surgical techniques, covering a wide array of topics, from chronic kidney disease to minimally invasive surgeries. Attendees will engage with global experts, sharing knowledge on cutting-edge practices, including artificial intelligence, regenerative medicine, and personalized therapies.

The event emphasizes practical solutions for improving patient outcomes, offering insights that can be immediately applied in clinical settings. Moreover, it presents a unique chance to network with leaders in the field, fostering collaborative efforts that could shape the future of nephrology and urology.

Set in the historic city of Rome, this conference combines professional development with the opportunity to experience the cultural richness of one of Europe’s most iconic cities, making it an enriching and valuable experience for all participants.

• Showcasing your achievements – present your research, projects, or initiatives to an international audience of colleagues, experts, and stakeholders.
• Demonstrating effective strategies – share your successful ideas, methodologies, and interventions that have proven effective in improving healthcare for rare neuromuscular conditions that can be adapted by others.
• Fostering collaboration – spark meaningful conversations, forge partnerships, and initiate collaborations with teams from around the world, encouraging a supportive network dedicated to advancing neuromuscular care.

1. Collaborative projects that highlight initiatives that facilitate the enhancement of healthcare for rare neuromuscular conditions through cooperation and partnership.
2. Partnership working that shows how your organisation has collaborated with TREAT-NMD to benefit the global neuromuscular community.
3. Utilisation of TREAT-NMD resources to advance research, clinical care, or patient advocacy efforts.

•  Abstracts should be concise and informative, clearly outlining the objectives, methods, results, and conclusions of your work.
•  Submissions must align with the themes and focus areas of the TREAT-NMD 2025 Conference.
• Abstracts should adhere to the specified format and guidelines provided on the conference website.